Karyopharm Therapeutics reported $137.4M in Cash and Equivalent for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cash And Equivalent Change
Acceleron Pharma XLRN:US $ 336.46M 0.26M
Amgen AMGN:US $ 11969M 5339M
AstraZeneca AZN:LN 7067M 8500M
Astrazeneca AZN:US $ 7067M 8500M
Avrobio Inc AVRO:US $ 201.37M 25.07M
Biocryst Pharmaceuticals BCRX:US $ 199.6M 10.72M
Bristol Myers Squibb BMY:US $ 13540M 2516M
Eli Lilly And LLY:US $ 3788.2M 568.2M
Enanta Pharmaceuticals ENTA:US $ 57.21M 52.6M
Epizyme EPZM:US $ 124.52M 44.35M
GlaxoSmithKline GSK:LN 3453M 50M
Karyopharm Therapeutics KPTI:US $ 137.4M 3.91M
Macrogenics MGNX:US $ 190.53M 1.56M
Mirati Therapeutics MRTX:US $ 176.78M 82.21M
Nektar Therapeutics NKTR:US $ 54.02M 98.33M
Novartis NVS:US $ 7211M 2094M
Novartis NOVN:VX SF 7211M 2094M
Regeneron Pharmaceuticals REGN:US $ 3432.4M 1360.2M
Sangamo Biosciences SGMO:US $ 176.95M 7.08M
Takeda 4502:JP Y 607881M 47039M
Tg Therapeutics TGTX:US $ 381.4M 20.31M
Ultragenyx Pharmaceutical RARE:US $ 197.54M 93.34M
Xencor XNCR:US $ 41.2M 74.64M
YTE INCY:US $ 1999.02M 201.44M